Free Trial

Immunome (IMNM) SEC Filings & 10K Form

Immunome logo
$12.02 -0.42 (-3.38%)
(As of 12/17/2024 ET)

Recent Immunome SEC Filings

DateFilerForm TypeView
11/25/2024
7:35 AM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:41 AM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:33 AM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
9:33 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/13/2024
3:06 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:54 AM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/29/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Immunome (Subject)
Form SC 13G
10/08/2024
3:31 PM
Immunome (Filer)
Form S-3ASR
10/07/2024
6:14 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
6:26 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
1:18 PM
Immunome (Subject)
Rosett Max (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
8:05 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
8:07 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
2:21 PM
Higgins Jack (Reporting)
Immunome (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:48 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:51 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:54 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:56 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:36 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:40 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:10 PM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2024
7:52 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:54 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:56 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:59 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:01 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:05 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
8:08 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:48 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:49 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:13 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:11 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:48 AM
Immunome (Filer)
Form 424B5
05/14/2024
7:05 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:02 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
7:14 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
A conspiracy Trump won’t unseal (Ad)

New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.

This is the untold, true story of God’s Investment.
04/29/2024
7:12 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2024
3:12 PM
Immunome (Filer)
Form ARS
04/25/2024
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
3:40 PM
Immunome (Filer)
Form S-3ASR
03/28/2024
3:04 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
8:07 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2024
8:10 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
1:10 PM
Alpine Global Management, LLC (Filed by)
Immunome (Subject)
Form SC 13G/A
02/06/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
8:18 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
7:50 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
7:53 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:27 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:33 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2024
4:37 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:40 PM
Immunome (Issuer)
Lapetina Bob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
7:35 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMNM) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners